Rating Card

Unlock Expert's Rating and Top Picks Portfolio

Become a member Or, Sign In

Stock Opinions by Stephen Weiss, Founder, Short Hills Capital Partners


He's buying this week's dip including Facebook, Skyworks and Cleveland Cliffs. He holds 35% cash. Some stocks he bought were down 20% this week, far below Monday's dip. Copper prices will remain stable. However, steel prices are so high, so Cleveland Cliffs is merely a short-term buy and he's looking for an exit if prices partially recover.


He's buying this week's dip. These shares fell to $30, which is obscene compared to other carmakers. Overall, FedEx and Nike are talking about supply chain issues which he hears is worsening, not improving, as rising wages will narrow margins. So, he will likely return to high cash levels.


He's buying this week's dip. Dick's is down on today's Nike news about supply chain constraints. Dick's stock is very cheap and the managers offered good guidance.

merchandising / lodging

Market outlook He expects another rollover coming. He's buying this week's dip, but he's cautious. Tapering will begin at some point, but he sees signs that the pandemic is ending. This means the Fed won't need to continue its pandemic supports. No, he doesn't expect the sky to fall next week or month. He holds a barbell portfolio, but favours upside short-term. Momentum is still there.


He just bought it. It's cheap at 10x forward earnings. They're in a hot business--a in logistics and supply chains. A very cheap stock. They've gotten into new markets. It's low-risk given the low multiple. They will guide to an earnings number of $10/share. Earnings will be released on Wednesday. This is a long-term hold.

electrical / electronic

He just bought it. Oil is uninvestable, but you can trade it. Like this. Chevron is getting into carbon capture, making ESG strides. Oil will keep moving higher though eventually will return to Earth.

integrated oils

It had a huge run. When the pandemic ends, the prices on their shots will leap from $25 to $150-200 which is normal for booster shots. Think of the profitability and their pipeline of 34 drugs.

Pharma & Healthcare
Showing 1 to 7 of 7 entries
  • «
  • 1
  • »